title: Companies that want to charge a higher than basic price for a new drug will have to give evidence that it's worth it.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006113:United Kingdom